Key points are not available for this paper at this time.
By utilizing the strategies outlined above, it may be possible to exploit differences between tumor and somatic cell DRR pathways, specifically their DSB repair mechanisms, to improve the therapeutic ratio of IR.
Santivasi et al. (Fri,) studied this question.